---
topic: "vitamin-c"
period: "2026-02"
generated_at: "2026-02-19T02:04:15.637356+00:00"
total_articles: 479
---

# 維生素C文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 維生素C 相關文獻 479 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）11 篇，RCT 2 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 11 | 2.3% |
| Level 2 (RCT) | 2 | 0.4% |
| Level 3 (Clinical Trial) | 2 | 0.4% |
| Level 4 (Observational) | 2 | 0.4% |
| Level 5 (Review/Case Report/Other) | 462 | 96.5% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| other | 其他 | 268 | 55.9% |
| immune | 免疫調節 | 60 | 12.5% |
| cardiovascular | 心血管 | 44 | 9.2% |
| anti_aging | 抗衰老 | 42 | 8.8% |
| cognitive | 認知功能 | 38 | 7.9% |
| metabolic | 代謝 | 35 | 7.3% |
| energy | 活力 | 31 | 6.5% |
| musculoskeletal | 肌肉骨骼 | 28 | 5.8% |
| digestive | 消化 | 16 | 3.3% |
| skin | 皮膚 | 13 | 2.7% |
| sexual | 性功能 | 12 | 2.5% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| EPA | 58 |
| iron | 46 |
| NAC | 18 |
| calcium | 11 |
| fiber | 7 |
| vitamin C | 4 |
| collagen | 4 |
| zinc | 3 |
| stem cell | 3 |
| whey protein | 3 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| EPA + iron | 8 |
| iron + whey protein | 3 |
| NAC + calcium | 2 |
| EPA + NAC | 2 |
| EPA + stem cell | 2 |
| EPA + fiber | 2 |
| fiber + vitamin C | 2 |
| calcium + fiber | 2 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 其他 | 免疫調節 | 肌肉骨骼 | 心血管 | 抗衰老 | 代謝 |
|------|--------|--------|--------|--------|--------|--------|--------|
| EPA | 58 | 29 | 14 | 8 | 5 | 6 | 8 |
| iron | 46 | 29 | 7 | 3 | 3 | 4 | 3 |
| NAC | 18 | 10 | 2 | 3 | 1 | 2 | - |
| calcium | 11 | 3 | 1 | 4 | 4 | - | 1 |
| fiber | 7 | 3 | - | 3 | - | - | - |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 7 | 1.5% |
| Systematic Review | 4 | 0.8% |
| RCT | 2 | 0.4% |
| Clinical Trial | 2 | 0.4% |
| Observational | 2 | 0.4% |
| Review | 19 | 4.0% |
| Case Report | 12 | 2.5% |
| Other | 431 | 90.0% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[The Effect of Cranberry Consumption on C-Reactive Protein and Interleukin-6: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/41704730/)** — Food science & nutrition, 2026-02-01
   - 功效分類：immune

2. **[Pre-procedural C-reactive protein levels and carotid or intracranial artery restenosis: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41704432/)** — Atherosclerosis plus, 2026-03-01
   - 功效分類：immune

3. **[Evaluating the safety, pharmacokinetics, and antiparasitic activity of DSM265, a novel antimalarial plasmodium dihydroorotate dehydrogenase inhibitor: a systematic review and meta-analysis of early clinical trials.](https://pubmed.ncbi.nlm.nih.gov/41703549/)** — Malaria journal, 2026-02-17
   - 功效分類：other

4. **[Prevalence and Correlates of Adverse Childhood Experiences in LGBTQ+ Populations: A Narrative Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/41703448/)** — Trauma, violence & abuse, 2026-02-17
   - 功效分類：sexual

5. **[Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41701457/)** — International journal of clinical oncology, 2026-02-17
   - 功效分類：immune


### Level 2 證據（RCT）

1. **[Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial.](https://pubmed.ncbi.nlm.nih.gov/41702946/)** — Scientific reports, 2026-02-17
   - 功效分類：immune

2. **[A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.](https://pubmed.ncbi.nlm.nih.gov/41703781/)** — Clinical and translational science, 2026-02-01
   - 功效分類：musculoskeletal

